Carson Wealth (CWM LLC)
EGRX

Carson Wealth (CWM LLC)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,672
Closed -$9K – 5254
2024
Q2 		$9K Sell
1,672
-565
-25% -$2.46K ﹤0.01% 3640
2024
Q1 		$12K Sell
2,237
-2,085
-48% -$11.4K ﹤0.01% 3254
2023
Q4 		$23K Buy
4,322
+3,258
+306% +$32.2K ﹤0.01% 2711
2023
Q3 		$17K Buy
1,064
+484
+83% +$8.7K ﹤0.01% 2811
2023
Q2 		$11K Buy
580
+454
+360% +$10.8K ﹤0.01% 3047
2023
Q1 		$4K Sell
126
-110
-47% -$3.27K ﹤0.01% 3447
2022
Q4 		$7K Buy
236
+68
+40% +$2.16K ﹤0.01% 3041
2022
Q3 		$4K Buy
+168
New +$6.16K ﹤0.01% 3243

Other funds holding EGRX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EGRX Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2024, closing a stake of 1,672 shares — an estimated $9K sold.

Carson Wealth (CWM LLC) first reported a position in EGRX in Q3 2022 and held it in 8 quarters. The position peaked at $23K in Q4 2023. 65 funds tracked by Wall St. Rank hold EGRX as of Q3 2024.

  • Carson Wealth (CWM LLC) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 1,672 Eagle Pharmaceuticals, Inc. shares in Q3 2024, an estimated $9K.
  • Carson Wealth (CWM LLC) first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2022 and held it in 8 quarters.
  • Carson Wealth (CWM LLC)'s Eagle Pharmaceuticals, Inc. position peaked at $23K in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.